Drs. Trivedi, and Shoptaw thank you so much for the opportunity of exchanging our ideas in this very interesting and relevant discussion.
Despite stimulants being widely used worldwide, we have yet to see pharmacotherapy with strong results for the treatment of methamphetamine dependence.
Upon reviewing the existing evidence, it seems that these studies face the challenge of treatment non-adherence. An extended-release injectable would in fact improve treatment retention, but at a greater cost when compared to its oral formulation. When discussing cost-effectiveness, how would you suggest we overcome this potential barrier in a primary care setting?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.